BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36324370)

  • 1. Retracted: Correlations of Ezrin Expression with Pathological Characteristics and Prognosis of Osteosarcoma: A Meta-Analysis.
    Journal TSW
    ScientificWorldJournal; 2022; 2022():9860781. PubMed ID: 36324370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
    Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
    ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
    Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
    PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma.
    Xu-Dong S; Zan S; Shui-er Z; Li-na T; Wen-xi Y; Feng L; Yang Y
    Clin Invest Med; 2009 Apr; 32(2):E180-8. PubMed ID: 19331807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
    Wang YF; Shen JN; Xie XB; Wang J; Huang G
    Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: RUNX3 Expression Level Is Correlated with the Clinical and Pathological Characteristics in Endometrial Cancer: A Systematic Review and Meta-analysis.
    International BR
    Biomed Res Int; 2023; 2023():9789534. PubMed ID: 38075335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
    Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Abnormal COX2 Protein Expression May Be Correlated with Poor Prognosis in Oral Cancer: A Meta-Analysis.
    International BR
    Biomed Res Int; 2021; 2021():3284807. PubMed ID: 33681352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
    Boldrini E; Peres SV; Morini S; de Camargo B
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
    Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
    Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.
    Cui SQ; Wang H
    Tumour Biol; 2015 Sep; 36(9):6949-58. PubMed ID: 25854173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of the
    Zhong GX; Feng SD; Shen R; Wu ZY; Chen F; Zhu X
    Onco Targets Ther; 2017; 10():527-533. PubMed ID: 28223819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.
    Huang T; Zhou Y; Cao Y; Tao J; Zhou ZH; Hang DH
    Oncol Lett; 2024 Aug; 28(2):377. PubMed ID: 38939622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: DNA Damage Response Genes in Osteosarcoma.
    Osteoporosis JO
    J Oncol; 2022; 2022():9875928. PubMed ID: 36568641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2.
    Research International B
    Biomed Res Int; 2021; 2021():9851958. PubMed ID: 34373836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.